Not Signed In -
Positron Emission Tomography |
|
|
Image of a typical positron emission tomography (PET) facility Positron emission tomography (PET) is a nuclear medicine medical imaging technique which produces a three dimensional image or map of functional processes in the body. Description Maximum Intensity Projection (MIPS) of a typical 18F-FDG wholebody PET acquisition Schema of a PET acquisition process Schematic view of a detector block and ring of a PET scanner (here: Siemens ECAT Exact HR+) A short-lived ...
Wikipedia - [full article]
Positron Emission Tomography Clinical Trials
- Positron Emission Tomography in Detecting Testicle Cancer
ClinicalTrials.gov Identifier: NCT00045045 - Active, not recruiting
Testicular Cancer
- Effect of Respiratory Motion on Positron Emission Tomography Imaging
ClinicalTrials.gov Identifier: NCT00088361 - Completed
Healthy; Tomography; Emission Computed
- Magnetic Resonance Imaging and Fludeoxyglucose F18 Positron Emission Tomography in Diagnosing Patients With Plasmacytoma
ClinicalTrials.gov Identifier: NCT00109889 - Active, not recruiting
extramedullary plasmacytoma; isolated plasmacytoma of bone
- Positron Emission Tomography (PET)-Computed Tomography (CT) in Inflammatory Bowel Disease (IBD)
ClinicalTrials.gov Identifier: NCT00205062 - Recruiting
Inflammatory Bowel Diseases
- Positron Emission Tomography Using [11C]Rolipram to Measure Phosphodiesterase in the Brain and Body
ClinicalTrials.gov Identifier: NCT00250172 - Recruiting
Dosimetry
- The Utility of FDG-PET for Radiation Treatment in NSCLC
ClinicalTrials.gov Identifier: NCT00385164 - Recruiting
Lung Neoplasms; Positron Emission Tomography
- Positron Emission Tomography Imaging Using Tariquidar and Technetium Tc 94m Sestamibi in Treating Patients With Cancer
ClinicalTrials.gov Identifier: NCT00086853 - Active, not recruiting
Unspecified Adult Solid Tumor, Protocol Specific
- Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma
ClinicalTrials.gov Identifier: NCT00060008 - Recruiting
neurofibromatosis 1 and 2 (NF1 and NF2)
- Positron Emission Tomography Guided Therapy of Aggressive Non-Hodgkin's Lymphomas
ClinicalTrials.gov Identifier: NCT00554164 - Not yet recruiting
Lymphoma, High-Grade
- Positron Emission Tomography (PET) to Study Brain Signaling
ClinicalTrials.gov Identifier: NCT00044200 - Recruiting
Healthy
- PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients
ClinicalTrials.gov Identifier: NCT00343707 - Active, not recruiting
Social Anxiety Disorder
- Remission Evaluation Before Intensified Treatment in Lymphoma: Impact of Positron Emission Tomography (PET) Using Fluorine-18-Floro-Deoxyglucose (FDG) in the Therapeutic Prescription. Medico-Economic Randomised Study
ClinicalTrials.gov Identifier: NCT00169598 - Active, not recruiting
Lymphoma
- Positron Emission Tomography of Amyloid in Alzheimer''s Disease
ClinicalTrials.gov Identifier: NCT00205621 - Suspended
Alzheimer''s Disease
- Positron Emission Tomography Before Surgery in Evaluating Women With Primary or Recurrent Breast Cancer
ClinicalTrials.gov Identifier: NCT00039286 - Recruiting
stage II breast cancer; stage IIIA breast cancer; recurrent breast cancer
- Usefulness of FDG-PET for Advanced Cervical Cancer
ClinicalTrials.gov Identifier: NCT00146458 - Active, not recruiting
Cervical Cancer
- ADNI: Alzheimer's Disease Neuroimaging Initiative
ClinicalTrials.gov Identifier: NCT00106899 - Active, not recruiting
Alzheimer's Disease
- Positron Emission Tomography (PET) Interest in the Follow Up of Colorectal Cancer Stage II and III
ClinicalTrials.gov Identifier: NCT00199654 - Recruiting
Colorectal Cancer
- Evaluation of Acetabular Perfusion After Ganz Osteotomy by Positron Emission Tomography
ClinicalTrials.gov Identifier: NCT00119444 - Recruiting
Osteoarthritis
- Positron Emission Tomography (PET) Imaging in People With Gaucher Mutations
ClinicalTrials.gov Identifier: NCT00302146 - Recruiting
Glucocerebrosidase Mutations; Gaucher Disease
- Positron Emission Tomography Scanning and Epstein-Barr Virus DNA Levels in the Staging and Follow-Up of Nasopharyngeal Carcinoma.
ClinicalTrials.gov Identifier: NCT00188253 - Recruiting
Nasopharyngeal Carcinoma
- Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant
ClinicalTrials.gov Identifier: NCT00238368 - Recruiting
Lymphoma
- Use of [18F]FECNT in Positron Emission Tomography
ClinicalTrials.gov Identifier: NCT00083629 - Completed
- Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography Versus MRI
ClinicalTrials.gov Identifier: NCT00166179 - Recruiting
Coronary Artery Disease
- Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00547612 - Recruiting
Pancreatic Cancer
- A Phase II Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients with Known Or Suspected Soft Tissue Sarcoma
ClinicalTrials.gov Identifier: NCT00123786 - Active, not recruiting
Sarcoma
- Positron Emission Tomography in Rheumatoid Arthritis With Adalimumab (PETRA)
ClinicalTrials.gov Identifier: NCT00497614 - Recruiting
Rheumatoid Arthritis
- The Use of Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) to Assess the Effects of Anti-Neoplastic Therapy on Tumor Associated Vasculature
ClinicalTrials.gov Identifier: NCT00001709 - Recruiting
Neoplasm
- Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer
ClinicalTrials.gov Identifier: NCT00081094 - Active, not recruiting
adult primary hepatocellular carcinoma; recurrent adult primary liver cancer; localized resectable adult primary liver cancer
- 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology
ClinicalTrials.gov Identifier: NCT00207298 - Recruiting
Brain Neoplasms; Lung Neoplasms; Lymphoma; Melanoma; Colorectal Neoplasms
- Impact of Positron Emission Tomography Imaging Prior to Liver Resection for Colorectal Adenocarcinoma Metastases(PETCAM)
ClinicalTrials.gov Identifier: NCT00265356 - Recruiting
Colorectal Cancer; Liver Metastases
- Positron Emission Tomography Using 3'-Deoxy-3'-(18F) Fluorothymidine in Treating Women With Locally Advanced Cancer in One Breast Who Are Receiving Chemotherapy
ClinicalTrials.gov Identifier: NCT00534274 - Recruiting
Breast Cancer
- Detection of Plaque Inflammation by Positron Emission Tomography (PET)-Effects of Simvastatin on Plaque Inflammation
ClinicalTrials.gov Identifier: NCT00114504 - Recruiting
Atherosclerosis
- Positron Emission Tomography Using Carbon-11 Acetate in Finding Metastasis and Predicting Recurrence in Patients with Newly Diagnosed Prostate Cancer Who Are At Risk for Recurrence After Treatment
ClinicalTrials.gov Identifier: NCT00121212 - Recruiting
stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- A Positron Emission Tomography (PET) Study to Assess the Degree of Dopamine-2 (D2) Receptor Occupancy in the Human Brain After Single Doses of BL-1020 or Perphenazine in Healthy Male Subjects Using [11C]Raclopride as PET Tracer
ClinicalTrials.gov Identifier: NCT00480246 - Recruiting
Healthy
- Study Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Locally Advanced (T3-T4 and./or N1)Primary Rectal Cancer Patients
ClinicalTrials.gov Identifier: NCT00574353 - Recruiting
Primary Rectal Cancer
- Proton Nuclear Magnetic Resonance Spectroscopic Imaging Compared With Fludeoxyglucose F 18 Positron Emission Tomography Scanning in Determining Biologic or Metabolic Tumor Activity in Young Patients With Brain Tumors
ClinicalTrials.gov Identifier: NCT00070512 - Recruiting
Brain and Central Nervous System Tumors
- Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial
ClinicalTrials.gov Identifier: NCT00316901 - Recruiting
Kidney Cancer; Melanoma (Skin)
- Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00227539 - Recruiting
Lung Cancer
- Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas
ClinicalTrials.gov Identifier: NCT00276770 - Recruiting
Adult Astrocytic Tumors; Adult Brain Stem Glioma; Adult Brain Tumor; Adult Ependymal Tumors; Adult Oligodendroglial Tumors; Mixed Gliomas
- Positron Emission Tomography Scan and CT Scan in Planning Radiation Therapy for Patients With Stage II or Stage III Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00310219 - Recruiting
Lung Cancer
- Molecular Imaging Modality by Positron Emission Tomography Using 18F-X : Study of Microglial Activation in Amyotrophic Lateral Sclerosis
ClinicalTrials.gov Identifier: NCT00563537 - Recruiting
Amyotrophic Lateral Sclerosis; Bulbar Disease; Spinal Disease
- Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00083083 - Recruiting
stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
- Zoledronic Acid and Positron Emission Tomography in Treating Patients With Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00559897 - Not yet recruiting
Lung Cancer; Metastatic Cancer
- Positron Emission Tomography Using Fluorine F 18 EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors
ClinicalTrials.gov Identifier: NCT00110032 - Completed
adult brain tumor
- Fluorine-18-α–Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer
ClinicalTrials.gov Identifier: NCT00464282 - Completed
Carcinoma, Non-Small-Cell Lung
- Positron Emission Tomography Using 11C Topotecan in Predicting Response to Treatment in Patients With Brain Metastases Due to Ovarian, Small Cell Lung, or Other Cancer
ClinicalTrials.gov Identifier: NCT00253461 - Recruiting
Brain and Central Nervous System Tumors; Lung Cancer; Ovarian Cancer; Unspecified Adult Solid Tumor, Protocol Specific
- Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00110006 - Recruiting
adult diffuse large cell lymphoma; adult non-Hodgkin's lymphoma; anaplastic large cell lymphoma; grade 3 follicular lymphoma; Mantle Cell Lymphoma
- Cervical Nodal Metastasis in Squamous Cell Carcinoma of the Head and Neck - Novel Magnetic Resonance Imaging (MRI), Fluorodeoxyglucose-Positron-Emission Tomography (FDG-PET), and Histopathologic Correlation
ClinicalTrials.gov Identifier: NCT00313027 - Recruiting
Head and Neck Cancer; Carcinoma, Squamous Cell; Metastasis
- Positron Emission Tomography Using Fluoromisonidazole F 18 and Fludeoxyglucose F 18 to Find Oxygen in Tumor Cells of Patients Undergoing Treatment for Newly Diagnosed Stage III or Stage IV Cervical Cancer
ClinicalTrials.gov Identifier: NCT00559377 - Not yet recruiting
Cervical Cancer
- Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma
ClinicalTrials.gov Identifier: NCT00068146 - Recruiting
Lymphoproliferative Disorders; Lymphoma
- Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-Tumoral Pharmacokinetics of 5-Fluorouracil in Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00165568 - Completed
Colorectal Cancer; Neoplasm Metastasis
- A Phase II Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients with Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00123747 - Recruiting
Lung Neoplasms
- Positron Emission Tomography in Determining Stage of Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00004867 - Completed
stage I esophageal cancer; stage II esophageal cancer; stage III esophageal cancer; stage IV esophageal cancer; ...
- Para-Aortic Lymph Nodal Staging and Evaluation of Treatment Outcome by 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in Advanced Cancer Cervix
ClinicalTrials.gov Identifier: NCT00193752 - Recruiting
Cancer of Cervix; Cervical Cancer; Cancer of the Cervix; Cervix Cancer
- Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity
ClinicalTrials.gov Identifier: NCT00029926 - Completed
Lupus Erythematosus; Systemic
- Positron Emission Tomography and Magnetic Resonance Imaging to Evaluate Synovial Blood Flow in Rheumatoid Arthritis Patients
ClinicalTrials.gov Identifier: NCT00014794 - Completed
Rheumatoid Arthritis
- Positron Emission Tomography in Patients with Breast Cancer
ClinicalTrials.gov Identifier: NCT00001385 - Completed
Breast Neoplasms
- A Phase II Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients with Known Or Suspected Cancers of Low Incidence
ClinicalTrials.gov Identifier: NCT00123773 - Recruiting
Sarcoma; Multiple Myeloma; Testicular Neoplasm; Ovarian Neoplasm; Kidney Neoplasm
- 18F-Fluoride Positron Emission Tomography (PET) in Paget's Disease of Bone
ClinicalTrials.gov Identifier: NCT00306046 - Completed
Paget's Disease of Bone
- Pre-Treatment Positron Emission Topography (PET) Scanning for Increasing Success in Antidepressant Treatment
ClinicalTrials.gov Identifier: NCT00456014 - Recruiting
Depression
- Positron Emission Tomography Imaging of Dopamine Receptors Using the Tracer [11C]NNC-112
ClinicalTrials.gov Identifier: NCT00088517 - Completed
Healthy
- Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00004138 - Completed
stage I non-small cell lung cancer; stage II non-small cell lung cancer; Squamous Cell Lung Cancer; large cell lung cancer; ...
- A Phase I/II, Phase III and Extended Phase III Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients with Cancer Or Suspected Cancer
ClinicalTrials.gov Identifier: NCT00123760 - Recruiting
Brain Neoplasm; Lung Neoplasm; Thyroid Neoplasm; Colorectal Neoplasm; Lymphoma
- Study the Role of Positron Emission Mammography in Pre-Surgical Planning for Breast Cancer
ClinicalTrials.gov Identifier: NCT00484614 - Recruiting
Breast Cancer
- Comparison of Cardiac Computed Tomographic Angiography (CTA) to Tc-99m Single Photon Emission Computed Tomography (SPECT)
ClinicalTrials.gov Identifier: NCT00449943 - Recruiting
Coronary Artery Disease
- Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy & Positron Emission Tomography in the Localization of Recurrent Colorectal Carcinoma in Patients with Rising Serum CEA Levels in the Absence of Imageable Disease by Conventional Modali
ClinicalTrials.gov Identifier: NCT00001568 - Completed
Colorectal Neoplasm
- Dutch Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA). PET Sub Study
ClinicalTrials.gov Identifier: NCT00228514 - Completed
Rosuvastatin; Heart Failure; Positron Emission Tomography (PET)
- PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery
ClinicalTrials.gov Identifier: NCT00004891 - Active, not recruiting
stage II rectal cancer; stage III rectal cancer; Stage IV rectal cancer
- Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11
ClinicalTrials.gov Identifier: NCT00015301 - Completed
Cocaine-Related Disorders; Substance-Related Disorders
- Assessment of Lung Inflammation in Patients with Atopic Asthma Using Positron Emission Tomography
ClinicalTrials.gov Identifier: NCT00001759 - Completed
Asthma; Hypersensitivity; Lung Diseases; Wegener's Granulomatosis
- Neoadjuvant Irinotecan and Cisplatin Followed By Surgical Resection in Treating Patients With Locally Advanced Cancer of the Stomach or Gastroesophageal Junction
ClinicalTrials.gov Identifier: NCT00062374 - Active, not recruiting
adenocarcinoma of the stomach; stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer
- Positron Emission Tomography to Measure Pain and Pain Control
ClinicalTrials.gov Identifier: NCT00001307 - Completed
Healthy; Hyperalgesia; Pain; Peripheral Nervous System Disease
- Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes
ClinicalTrials.gov Identifier: NCT00368199 - Recruiting
Parkinson's Disease; Parkinsonian Syndrome; Multiple System Atrophy; Supranuclear Palsy, Progressive; Essential Tremor; Vascular Parkinsonism; Drug Induced Parkinsonism
- Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma
ClinicalTrials.gov Identifier: NCT00072488 - Recruiting
Ewing's family of tumors; childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; childhood rhabdomyosarcoma; Neuroblastoma
- A Phase II Study of Fluorodeoxyglucose (FluGlucoScan) in Patients with Breast Cancer: Correlation with Histologic Findings of Sentinel Node Biopsies and Axillary Dissection
ClinicalTrials.gov Identifier: NCT00123799 - Terminated
Breast Neoplasms
- PET Scan in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002981 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Gemcitabine, Docetaxel, and Capecitabine in Treating Patients with Cancer of Unknown Primary Origin
ClinicalTrials.gov Identifier: NCT00119314 - Active, not recruiting
newly diagnosed carcinoma of unknown primary; recurrent carcinoma of unknown primary
- Single Photon Emission Computed Tomography (SPECT) to Study Paroxysmal Hyperkinetic Movement Disorders
ClinicalTrials.gov Identifier: NCT00051337 - Completed
Hyperkinesis
- A Safety and Efficacy Study Using Computed Tomography (CT) of the Head and Body in Patients That Are Referred for a CT by Their Physician
ClinicalTrials.gov Identifier: NCT00244140 - Recruiting
Computed Tomography; Diagnostic Imaging
- Multi-Detector Spiral Computed Tomography Alone versus Combined Strategy with Lower Limb Compression Ultrasonography in Outpatients Suspected of Pulmonary Embolism
ClinicalTrials.gov Identifier: NCT00117169 - Active, not recruiting
Pulmonary Embolism
- PET Scans in Patients With Locally Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00109785 - Recruiting
stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; Male Breast Cancer
- Single Photon Emission Computed Tomography to Study Receptors in Parkinson's Disease
ClinicalTrials.gov Identifier: NCT00058721 - Completed
Parkinson Disease
- Evaluating the Infant Complex Congenital Heart Diseas by Multidetector Computed Tomography
ClinicalTrials.gov Identifier: NCT00155285 - Recruiting
Heart Diseases
- PET Scans in Diagnosing Primary or Recurrent Cervical Cancer in Patients Who Are Undergoing Surgery
ClinicalTrials.gov Identifier: NCT00003429 - Completed
stage I cervical cancer; stage II cervical cancer; recurrent cervical cancer
- Computed Tomography for Early Detection of Cancer in Women Who Are at Risk for Lung Cancer
ClinicalTrials.gov Identifier: NCT00012103 - Active, not recruiting
Non-small cell lung cancer; Small Cell Lung Cancer
- Optical Coherence Tomography of Airway and Pleural Disorders
ClinicalTrials.gov Identifier: NCT00580892 - Enrolling by invitation
Endobronchial Disorder
- Helical Computed Tomography Compared With Chest X-Ray in Screening Individuals at High Risk for Lung Cancer
ClinicalTrials.gov Identifier: NCT00028808 - Active, not recruiting
Small Cell Lung Cancer; Non-small cell lung cancer
- Computed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00084526 - Active, not recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Computed Tomography in Detecting Movement of the Esophagus in Patients Undergoing Radiation Therapy to the Chest
ClinicalTrials.gov Identifier: NCT00433524 - Active, not recruiting
Unspecified Adult Solid Tumor, Protocol Specific
- A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging
ClinicalTrials.gov Identifier: NCT00556114 - Enrolling by invitation
Retina; Glaucoma; Diabetic Retinopathy; Age-Related Macular Degeneration
- Optical Coherence Tomography (OCT) Imaging of Post Coil Aneurysm Healing.
ClinicalTrials.gov Identifier: NCT00556309 - Enrolling by invitation
Aneurysm
- Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients with HIV and Hepatitis C Virus
ClinicalTrials.gov Identifier: NCT00006643 - Completed
HIV Infections; Hepatitis C
- Optical Coherence Tomography of the Gastrointestinal Tract
ClinicalTrials.gov Identifier: NCT00579748 - Active, not recruiting
Barrett's Esophagus With or Without Dysplasia; Patients With Early Esophageal or Gastric Cancer; Patients With Intestinal Metaplasia of the Stomach
- Performance of the Water-Enema Computed Tomography (WE-CT)
ClinicalTrials.gov Identifier: NCT00188110 - Recruiting
Colon Cancer
- Computed Tomography (CT) in Head and Neck Patients
ClinicalTrials.gov Identifier: NCT00188656 - Recruiting
Lung Tumors
- Corneal and Anterior Segment Optical Coherence Tomography - Optovue
ClinicalTrials.gov Identifier: NCT00532051 - Recruiting
Cataract
- Kidney Stone Structural Analysis By Helical Computed Tomography (CT)
ClinicalTrials.gov Identifier: NCT00169780 - Recruiting
Nephrolithiasis
- Near Infrared Optical Coherence Tomography of the Upper Aero-Digestive Tract
ClinicalTrials.gov Identifier: NCT00544427 - Enrolling by invitation
Upper Areo-Digestive Tract
- The Study of Human Atherosclerosis by Polarization-Sensitive Optical Coherence Tomography
ClinicalTrials.gov Identifier: NCT00173238 - Recruiting
Pathological Conditions, Anatomical
- Tracking Optical Coherence Tomography
ClinicalTrials.gov Identifier: NCT00343603 - Recruiting
Macular Degeneration; Glaucoma; Diabetic Retinopathy; Choroidal Disease
Resources
- Positron Emission Tomography (National Women's Health Information Center)
- Positron Emission Tomography: The Power of Molecular Imaging (University of California, Los Angeles)
email this page
print this page
bookmark this page
feedback on this page
